These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 20373280

  • 1. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D, Uruski P, Wierusz-Wysocka B.
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [Abstract] [Full Text] [Related]

  • 2. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C, Kolouskovà S, Linn T, Ludvigsson J, Madàcsy L, Mrozikiewicz AS, Mrozikiewicz PM, Podar T, Vavrinec J, Vialettes B, Visalli N, Yilmaz T, Browne PD, IMDIAB group.
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [Abstract] [Full Text] [Related]

  • 3. Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics.
    Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D.
    Diabet Med; 2010 Aug; 27(8):911-7. PubMed ID: 20653749
    [Abstract] [Full Text] [Related]

  • 4. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D, Khan R.
    Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864
    [Abstract] [Full Text] [Related]

  • 5. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. I. Effects on blood glucose control.
    Chlup R, Vaverková H, Bartek J.
    Exp Clin Endocrinol Diabetes; 1997 Nov; 105 Suppl 2():70-3. PubMed ID: 9288550
    [Abstract] [Full Text] [Related]

  • 6. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [Abstract] [Full Text] [Related]

  • 7. [Is intensive functional insulin therapy the method of choice in newly diagnosed type-1 diabetes mellitus?].
    Araszkiewicz A, Zozulińska D, Trepińska M, Wierusz-Wysocka B.
    Pol Merkur Lekarski; 2004 Nov; 17(101):463-6. PubMed ID: 15754632
    [Abstract] [Full Text] [Related]

  • 8. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.
    Acerini CL, Cheetham TD, Edge JA, Dunger DB.
    Diabetologia; 2000 Jan; 43(1):61-8. PubMed ID: 10663217
    [Abstract] [Full Text] [Related]

  • 9. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I, Almazov VA, Shlyakhto E.
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [Abstract] [Full Text] [Related]

  • 10. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY, Naumenkova IV, Antsiferov MB, Dedov II.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [Abstract] [Full Text] [Related]

  • 11. Intensive insulin treatment in diabetic children.
    Ludvigsson J, Bolli GB.
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [Abstract] [Full Text] [Related]

  • 12. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.
    Circulation; 2005 May 17; 111(19):2446-53. PubMed ID: 15867184
    [Abstract] [Full Text] [Related]

  • 13. Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes.
    Ashraf A, Mick G, Meleth S, Wang X, McCormick K.
    Med Sci Monit; 2007 Dec 17; 13(12):CR533-7. PubMed ID: 18049431
    [Abstract] [Full Text] [Related]

  • 14. [Diabetes mellitus, but which type?].
    Hoekstra JB, de Koning EJ.
    Ned Tijdschr Geneeskd; 2004 Apr 17; 148(16):761-4. PubMed ID: 15129562
    [Abstract] [Full Text] [Related]

  • 15. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S, Estacio RO, Jeffers B, Schrier RW.
    Proc Assoc Am Physicians; 1997 Mar 17; 109(2):181-9. PubMed ID: 9069587
    [Abstract] [Full Text] [Related]

  • 16. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
    Durlach V, Gillery P, Bertin E, Grulet H, Gross A, Leutenegger M.
    Diabetes Metab; 1998 Apr 17; 24(2):124-30. PubMed ID: 9592636
    [Abstract] [Full Text] [Related]

  • 17. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.
    Diabetes Metab; 2010 Feb 17; 36(1):64-70. PubMed ID: 20060765
    [Abstract] [Full Text] [Related]

  • 18. [Effect of glycemic equilibrium on micro-angiopathic complications in insulin-dependent diabetes: results of recent studies].
    Zinman B.
    Journ Annu Diabetol Hotel Dieu; 1994 Feb 17; ():93-100. PubMed ID: 8051834
    [No Abstract] [Full Text] [Related]

  • 19. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ, Montgomery PA.
    Pharmacotherapy; 1998 Feb 17; 18(5):961-72. PubMed ID: 9758308
    [Abstract] [Full Text] [Related]

  • 20. Factors related to insulin resistance in type 1 diabetic patients treated with intensive insulin therapy from the onset of the disease.
    Araszkiewicz A, Uruska A, Zozulinska-Ziolkiewicz D, Pilacinski S, Wierusz-Wysocka B.
    Diabetes Res Clin Pract; 2010 Nov 17; 90(2):e23-4. PubMed ID: 20541277
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.